Cargando…
CXCL9 promotes prostate cancer progression through inhibition of cytokines from T cells
Chemokines have been demonstrated to serve an important role in a variety of diseases, particularly in tumor progression. There have been numerous studies that have reported that T cells serve major roles in tumor progression. However, the function of CXC motif chemokine ligand 9 (CXCL9) in prostate...
Autores principales: | Tan, Shanfeng, Wang, Kai, Sun, Fuguang, Li, Yang, Gao, Yisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072144/ https://www.ncbi.nlm.nih.gov/pubmed/29901197 http://dx.doi.org/10.3892/mmr.2018.9152 |
Ejemplares similares
-
CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression
por: Gao, Hui-Feng, et al.
Publicado: (2020) -
Progression of prostate carcinoma is promoted by adipose stromal cell-secreted CXCL12 signaling in prostate epithelium
por: Su, Fei, et al.
Publicado: (2021) -
Monocytes secrete CXCL7 to promote breast cancer progression
por: Wang, Yi-Hsiang, et al.
Publicado: (2021) -
The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
por: Yin, Xiaowan, et al.
Publicado: (2019) -
Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
por: Murdamoothoo, Devadarssen, et al.
Publicado: (2021)